Research presented at the American Cardiology Conference (ACC) in Chicago last week showed that treatment with the diuretic indapamide (1.5g daily) could cut total mortality by 21 per cent and stroke risk by 30 per cent.
The randomised controlled study, called HYVET, included 3,845 patients aged an average of 84 years.
Patients had a systolic BP of 160–99mmHg and a diastolic BP below 110mmHg.
The patients were followed for up for an average of 1.8 years. During which time, 48 per cent of those in the treatment arm reached the target BP of 150/80mmHg, compared with 20 per cent given placebo.
Comment below and tell us what you think